Projects per year
Fingerprint
Dive into the research topics where Theresa Lentner is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 1 Active
-
HUMPHREY: Molecular Profiling of Patients’ Tumors to Find Potential Targets in Advanced Colorectal Cancer – HUMPHREY (Histology specimen Utilization for Molecular Profiling of cancer in Hitherto Resistant or Exhausted to TherapY)
Lentner, T. (PI)
01.07.2023 → 30.06.2025
Project: Forschungsimpulse › Research Time Out (RTO)
Research output
-
Acute myeloid leukemia patient with active disseminated tuberculosis bridged to transplant with reduced 14-day venetoclax and azacitidine schedule
Lentner, T. & Krajnik, G., Feb 2024, In: Memo - Magazine of European Medical Oncology. 17, 1, p. 67-70 4 p.Research output: Journal article (peer-reviewed) › Case report
Open Access -
Immunotherapy for Microsatellite-Stable Metastatic Colorectal Cancer: Can we close the Gap between Potential and Practice?
Hamid, M. A., Pammer, L. M., Lentner, T. K., Doleschal, B., Gruber, R., Kocher, F., Gasser, E., Jöbstl, A., Seeber, A. & Amann, A., Oct 2024, In: Current Oncology Reports. 26, 10, p. 1258-1270 13 p.Research output: Journal article (peer-reviewed) › Review article
Open Access3 Citations (Scopus) -
Mechanisms of resistance to immunotherapy
Blauensteiner, B., Lentner, T. & Moreno-Viedma, V., Aug 2024, (E-pub ahead of print) Principles of Immunotherapy Breast and Gastrointestinal Cancers. Elsevier, p. 1-33Research output: Contribution to book/report/conference proceeding › Chapter in book/report
-
Austrian tricentric real-life analysis of molecular profiles of metastatic biliary tract cancer patients
Taghizadeh, H., Schmalfuss, T., Maj-Hes, A., Singer, J. & Prager, G. W., 10 May 2023, In: Frontiers in Oncology. 13, p. 1143825 1143825.Research output: Journal article (peer-reviewed) › Journal article
Open Access1 Citation (Scopus) -
Bevacizumab mitigates codon-specific effects of trifluridine/tipiracil on efficacy outcome parameters in metastatic colorectal cancer
Doleschal, B., Taghizadeh, H., Lentner, T., Riedl, J. M., Granitzer, J., Morariu, D., Decker, J., Aichberger, K. J., Webersinke, G., Kirchweger, P., Petzer, A. & Rumpold, H., Dec 2023, In: ESMO Open. 8, 6, p. 102064 102064.Research output: Journal article (peer-reviewed) › Journal article
Open Access1 Citation (Scopus)